Dr. Igor Puzanov discusses updates on his current clinical trial collaboration with the University at Buffalo, and regional community health systems, geared toward treating the critical and severe symptoms of COVID-19.

Experts & Moderators

 

Igor Puzanov, MD, MSci, FACP

Director, Early Phase Clinical Trials Program

Chief of Melanoma

Co-Leader, CCSG Experimental Therapeutics Program

Professor of Oncology, Department of Medicine

 

Rebecca Vogt

Moderator

Media Relations Specialist